Adoptive Immunotherapy of Refractory Viral Infections after Allogeneic HSCT: An Academic Network Framing the use of an Atmp under Hospital Exemption - Université de Lorraine Accéder directement au contenu
Poster Année : 2020

Adoptive Immunotherapy of Refractory Viral Infections after Allogeneic HSCT: An Academic Network Framing the use of an Atmp under Hospital Exemption

Laurence Clement
  • Fonction : Auteur
Jerome Larghero
  • Fonction : Auteur
  • PersonId : 887236
Hélène Rouard
  • Fonction : Auteur
  • PersonId : 953378
EFS

Dates et versions

hal-03632344 , version 1 (06-04-2022)

Identifiants

Citer

Yingying Wang, Marcelo de Carvalho-Bittencourt, Typhaine Pierre, Mélanie Gauthier, Veronique Decot, et al.. Adoptive Immunotherapy of Refractory Viral Infections after Allogeneic HSCT: An Academic Network Framing the use of an Atmp under Hospital Exemption. 46th European Society for Blood and Marrow Transplantation (EBMT) Annual Meeting (Virtual), Aug 2020, Virtual Meeting, France. 55 (S1), pp.181-714, 2020, ⟨10.1038/s41409-020-01120-w⟩. ⟨hal-03632344⟩
12 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More